Your browser doesn't support javascript.
loading
Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation.
Khouri, Maria R; Jabbour, Elias J; Gulbis, Alison M; Turturro, Francesco; Ledesma, Celina; Korbling, Martin; Samuels, Barry I; Ahmed, Sairah; Alousi, Amin M; Ciurea, Stefan O; Marin, David; Patel, Krina K; Popat, Uday R; Bueso-Ramos, Carlos E; Bassett, Roland L; Khouri, Issa F.
Afiliação
  • Khouri MR; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jabbour EJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gulbis AM; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Turturro F; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ledesma C; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Korbling M; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Samuels BI; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ahmed S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Alousi AM; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ciurea SO; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Marin D; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Patel KK; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Popat UR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bueso-Ramos CE; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bassett RL; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Khouri IF; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: ikhouri@mdanderson.org.
Biol Blood Marrow Transplant ; 23(8): 1405-1410, 2017 Aug.
Article em En | MEDLINE | ID: mdl-28495642
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Talidomida / Leucemia Linfocítica Crônica de Células B / Transfusão de Linfócitos / Transplante de Células-Tronco / Doença Enxerto-Hospedeiro Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Talidomida / Leucemia Linfocítica Crônica de Células B / Transfusão de Linfócitos / Transplante de Células-Tronco / Doença Enxerto-Hospedeiro Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article